Regional Analysis

Global Generic Sterile Injectables Market – Regional Analysis

On the basis of region, global generic sterile injectables market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa

Among regions, North America generic sterile injectables market is expected to hold a dominant position during the forecast period, owing to the launching of the new generic injectables in the region. For instance, in February 2022, Dr Reddy's Laboratories Ltd announced the launch of vasopressin injection, which is used to control frequent urination, increased thirst, and loss of water caused by diabetes, in the U.S. market. It is a generic version of Par Pharmaceuticals' Vasostrict. Par Pharmaceuticals is a company that develops generic pharmaceutical and branded injectable products.

Furthermore, Europe is also estimated to witness significant growth in the global generic sterile injectables market, owing to increasing prevalence of chronic conditions such as cardiovascular diseases, Alzheimer's diseases and hypertension. For instance, according to the data provided by the National Health Service, Scotland as of May 2021, it is estimated that Alzheimer's disease affects around 850,000 people in the U.K.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa